Filtered By:
Condition: Chronic Obstructive Pulmonary
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 1666 results found since Jan 2013.
Use of ICS/LABA Combinations or LAMA is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma
Conclusions LAMA or ICS/LABA combinations use was associated with a lower risk of acute exacerbation in patients with COPD and asthma in this study.
Source: The Journal of Allergy and Clinical Immunology: In Practice - February 10, 2018 Category: Allergy & Immunology Source Type: research
Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle Cells
Conclusions: This is the first report that P-TEFb is involved in IL-17F-induced IL-8 expression and that steroids diminish it via the inhibition of CDK9 phosphorylation. IL-17F and P-TEFb might be novel therapeutic targets for airway inflammatory diseases.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - April 12, 2018 Category: Allergy & Immunology Source Type: research
Asthma ‐COPD Overlap Syndrome among subjects with newly diagnosed adult‐onset asthma
Allergy, EarlyView.
Source: Allergy - May 11, 2018 Category: Allergy & Immunology Authors: Y. ‐C. Wang
,
M. S. Jaakkola
,
T. K. Lajunen
,
C.‐H. Lai
,
J. J. K. Jaakkola Source Type: research
Practice Patterns for Chronic Respiratory Diseases in the Asia-Pacific Region: A Cross-Sectional Observational Study
Conclusions: Our findings, albeit mostly descriptive and influenced by between-country differences, suggest that practice patterns differ between physician types, and the disease burden may be substantial for patients presenting in general practice.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - June 6, 2018 Category: Allergy & Immunology Source Type: research
Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap
ConclusionSerum periostin levels were comparable between asthma and ACO, while YKL-40 was comparable between ACO and COPD. Combined assessment of serum periostin and YKL-40 may identify ACO.
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 6, 2018 Category: Allergy & Immunology Source Type: research
Advances in managing COPD related to α1‐antitrypsin deficiency, an under‐recognized genetic disorder
Allergy,Volume 0, Issue ja, -Not available-.
Source: Allergy - July 9, 2018 Category: Allergy & Immunology Authors: Timothy J. Craig
,
Maria Paula Henao Source Type: research
Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap
ConclusionSerum periostin levels were comparable between asthma and ACO, while YKL-40 was comparable between ACO and COPD. Combined assessment of serum periostin and YKL-40 may identify ACO.
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 10, 2018 Category: Allergy & Immunology Source Type: research
Chronic Rhinitis Is A High-Risk Comorbidity For 30-Day Re-Admission Of Patients With Asthma And Chronic Obstructive Pulmonary Disease
CONCLUSIONAND RELEVANCE: Comorbid CR is significantly associated with 30-day asthma- and COPD-related readmissions. These findings are useful for guiding healthcare professionals to focus on outpatient management of both the upper and lower respiratory tracts in order to reduce early readmission of asthma and COPD patients.
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 25, 2018 Category: Allergy & Immunology Source Type: research
Advances in managing COPD related to α1‐antitrypsin deficiency: An under‐recognized genetic disorder
Allergy, EarlyView.
Source: Allergy - July 27, 2018 Category: Allergy & Immunology Authors: Timothy J. Craig
,
Maria Paula Henao Source Type: research
Comparing the different diagnostic criteria of Asthma ‐COPD overlap
Allergy,Volume 0, Issue ja, -Not available-.
Source: Allergy - July 25, 2018 Category: Allergy & Immunology Authors: Yong Suk Jo
,
Yong Il Hwang
,
Kwang Ha Yoo
,
Tae ‐Hyung Kim
,
Myung Goo Lee
,
Sang Haak Lee
,
Kyeong‐Cheol Shin
,
Kwang Ho In
,
Hyoung Kyu Yoon
,
Chin Kook Rhee
, Source Type: research
Inhaled corticosteroid-related tuberculosis in the real world among patients with asthma and COPD: A 10-year nationwide population-based study
ConclusionAn increased risk of TB development may persist for 3 years after stopping the ICS and the risk is higher in patients with COPD regardless of the type of ICS used.
Source: The Journal of Allergy and Clinical Immunology: In Practice - October 17, 2018 Category: Allergy & Immunology Source Type: research
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma
ConclusionsThe use of LAMA or ICS/LABA combinations was associated with a lower risk of acute exacerbation in patients with COPD and asthma in this study.
Source: The Journal of Allergy and Clinical Immunology: In Practice - November 2, 2018 Category: Allergy & Immunology Source Type: research
Risk Factors for Return to the Emergency Department for Asthma: A Population-Based Study
ConclusionsNearly 1 in 8 individuals with a first ED visit for asthma returned to the ED within a year of the initial ED discharge. Targeting those at risk for ED return may help improve health care costs, productivity, and quality of life.
Source: The Journal of Allergy and Clinical Immunology: In Practice - November 2, 2018 Category: Allergy & Immunology Source Type: research
Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease
ConclusionsComorbid CR is significantly associated with 30-day asthma- and COPD-related readmissions. These findings are useful for guiding health care professionals to focus on outpatient management of both the upper and lower respiratory tracts to reduce early readmission of patients with asthma and COPD.
Source: The Journal of Allergy and Clinical Immunology: In Practice - December 29, 2018 Category: Allergy & Immunology Source Type: research
Can We Define Asthma-COPD Overlap (ACO) by Biomarkers?
Publication date: January 2019Source: The Journal of Allergy and Clinical Immunology: In Practice, Volume 7, Issue 1Author(s): Kenji Izuhara, Peter J. Barnes
Source: The Journal of Allergy and Clinical Immunology: In Practice - December 29, 2018 Category: Allergy & Immunology Source Type: research
